3P^® Consulting

Welcome to 3P^® Consulting

Upcoming or recent congress presentations

• FIGARO Study: Facilitated subcutaneous immunoglobulin treatment in patients with primary and secondary immunodeficiencies: IPIC 2022
• INISIGHTS-GHT registry: Investigating Significant Health Trends in Growth Hormone Treatments Registry: 65. Kongress der Dt. Ges. Endokrinologie 2022
• CORE: Noninterventional study on the usage and outcomes of IG subcutaneous (human) 20% solution in patients with primary immunodeficiency disease. ESID 2020

Recent scientific publications

• EXPERT study: Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 2022
• COMPERA registry: Refined 4-strata risk assessment model for pulmonary arterial hypertension. Eur Resp J 2021
• INSIGHTS-SVT registry: Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis. Eur J Vasc Endovasc Surg 2021
• RAHPP study: Facilitated subcutaneous immunoglobulin use in pediatric patients with primary or secondary immunodeficiency diseases. Immunotherapy 2021
• INSIGHTS-IPF registry: Lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis. Eur Resp J 2020
• DETECT study: Cardiovascular risk algorithms in primary care: Results from the DETECT study. Sci Rep 2019

Recent contributions to books

• Seltene Lungenerkrankungen. Springer Verlag 2022

About 3P^® Consulting

3P^® Consulting was founded iby a group of specialists in pharmaceutical medicine or clinical pharmacology who have held senior positions in industry (Medical Directors) and/or academia.
For over 20 years, 3P^® Consulting provides consulting and clinical development services to pharmaceutical companies and research organisations (including universities).

Our three main areas of expertise are:

• Consulting on regulatory, medical and medico-marketing issues for the pharmaceutical industry and universities
• Pharmacoepidemiological and public health research projects (registries, real world evidence generation)
• Scientific writing and communication

All senior staff members of 3P^® Consulting are medical doctors, and all members of the consulting staff are MDs and/or PhDs. Some staff members have teaching or consulting commitments at major medical faculties.

Together we have published more than 500 original papers, abstracts in peer-reviewed journals or have contributed to books. In addition, we have run a significant number of large-scale medical and medico-marketing projects.

Our senior staff members are on the steering boards of major clinical or epidemiological studies, or on the editorial boards of renowned scientific journals.

We provide consulting services for pharmaceutical companies and renowned universities/institutions. 3P^® Consulting advises leading international companies, as well as distinguished biotech and specialised firms.

We also consult on large-scale university-driven research projects. For example, studies include NISAS (sleep disorders, 20 000 patients), HYDRA (hypertension and diabetes, 45000 patients), DETECT (cardiovascular risk, 55000 patients), getABI (peripheral arterial disease, 6880 patients), COMPERA (pulmonary arterial hypertension, 11000 patients), INSIGHTS-IPF and INSIGHTS-ILD (pulmonary fibrosis, 1500 patients), INSIGHTS-SVT (superficial vein thrombosis, 1500 patients), INSIGHTS-GHT (growth hormone treatment, 1500 patients), and others.

Executive Staff

Prof. Dr. med. habil. David Pittrow

• MD, PhD (Dr. med. Dr. med. habil.)
• Board Certified Specialist in Pharmaceutical Medicine (FMH Switzerland)
• PhD in Clinical Pharmacology (Univ. Dresden, Germany)
• ECFMG physician accreditation (USA)
• Delegate 2003-2007 of the German Society for Clinical Pharmacology and Therapeutics to the Council of the European Association of Clinical Pharmacology and Therapeutics (EACPT)

Member of editorial boards:

• Current Drug Safety
• International Journal of Methods in Psychiatric Research (since 2010)
• European Journal of Clinical Investigation (guest editor 2004 - 2014)
• Current Medical Research and Opinion (guest editor 2007)

Publications: > 200 scientific papers, congress contributions and book chapters (see Medline)

Hirsch Factor (Google Scholar): 52
i10 Factor: 152

Prof. Dr. med. habil. Edgar Müller

• MD, PhD, FCP (Dr. med. Dr. med. habil.)
• Board Certified Specialist in Clinical Pharmacology
• PhD in Clinical Pharmacology (Univ. Dresden, Germany)
• Fellow of the American College of Clinical Pharmacology (FCP)

Member of editorial board:

• Journal of Public Health (guest editor 2010)

Publications: > 160 scientific papers, congress contributions and book chapters (see Medline)
Hirsch Factor: 28

Dr. med. Petra Patrizia Haller-Pittrow

• MD
• Board Certified Specialist in General Medicine (Germany)

Publications: > 30 scientific papers, congress contributions and book chapters (see Medline)

Services

Regulatory, Medical and Medico-marketing Consulting

• Phase I to IV development plans
• Consulting and streamlining of clinical projects
• Protocol development and study reports
• Expert statements of board certified Clinical Pharmacologists and other experts
• Briefing books and Expert Reports
• Responses to authorities
• Staff Trainings, SOP development, structural analyses
• Audits

Pharmacoepidemiological and Public Health research projects

• Consulting on design, implementation, interpretation and publishing
• Methodological research
• Study supervision
• Complete study conduct from planning to Clinical Study Report

Scientific Writing and Communication

• Strategic communication plans
• Medical writing (reviews, original papers, abstracts)
• Study protocols and reports
• Investigator brochures
• Expert reports, expert statements and monographs
• Clinical and Nonclinical Overviews
• Periodic Safety Update Reports
• Clinical and preclinical CTD documents
• SAE reporting and writing of narratives
• Germany: Expert statements §24 German Drug Law, Experience Reports
• Germany: Nutzenbewertung (G-BA), input to dossiers
• Scientific information retrieval
• Medical education materials
• Posters for scientific congresses
• Presentations, slide kits
• Books (including full project management)